Profile | GDS5420 / 59433_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 380.32 | 63 |
GSM1296119 | B_lesional_pre-dose | 269.85 | 57 |
GSM1296076 | C_lesional_pre-dose | 5.1 | 4 |
GSM1296092 | D_lesional_pre-dose | 138.9 | 48 |
GSM1296103 | E_lesional_pre-dose | 176.91 | 51 |
GSM1296078 | F_lesional_pre-dose | 88.95 | 41 |
GSM1296107 | G_lesional_pre-dose | 474.5 | 67 |
GSM1296109 | H_lesional_pre-dose | 469.41 | 66 |
GSM1296080 | I_lesional_pre-dose | 341.33 | 62 |
GSM1296090 | J_lesional_pre-dose | 38.2 | 28 |
GSM1296074 | K_lesional_pre-dose | 20.77 | 20 |
GSM1296111 | L_lesional_pre-dose | ||
GSM1296099 | M_lesional_pre-dose | 22.04 | 19 |
GSM1296086 | O_lesional_pre-dose | 79.8 | 39 |
GSM1296117 | P_lesional_pre-dose | 145.16 | 46 |
GSM1296113 | Q_lesional_pre-dose | 549.83 | 69 |
GSM1296096 | R_lesional_pre-dose | 129.88 | 46 |
GSM1296105 | S_lesional_pre-dose | 26.97 | 21 |
GSM1296098 | T_lesional_pre-dose | 233.3 | 55 |
GSM1296101 | U_lesional_pre-dose | 301.78 | 59 |
GSM1296121 | V_lesional_pre-dose | 155.06 | 48 |
GSM1296088 | W_lesional_pre-dose | 59.37 | 34 |
GSM1296082 | X_lesional_pre-dose | 146.15 | 49 |
GSM1296115 | Y_lesional_pre-dose | 339.98 | 61 |
GSM1296084 | Z_lesional_pre-dose | 135.95 | 46 |
GSM1296072 | B_lesional_day8 | 310.42 | 59 |
GSM1296069 | L_lesional_day8 | 3.26 | 2 |
GSM1296071 | P_lesional_day8 | 174.66 | 48 |
GSM1296070 | Y_lesional_day8 | 365.61 | 62 |
GSM1296073 | V_lesional_day8 | 139.81 | 47 |
GSM1296034 | A_lesional_day15 | 665.35 | 72 |
GSM1296041 | G_lesional_day15 | 485.52 | 67 |
GSM1296035 | R_lesional_day15 | 158.7 | 49 |
GSM1296038 | U_lesional_day15 | 89.09 | 40 |
GSM1296047 | B_lesional_day15 | 390.1 | 63 |
GSM1296039 | E_lesional_day15 | 147.09 | 48 |
GSM1296042 | H_lesional_day15 | 275.14 | 57 |
GSM1296043 | L_lesional_day15 | ||
GSM1296037 | M_lesional_day15 | 131.59 | 45 |
GSM1296046 | P_lesional_day15 | 151.21 | 46 |
GSM1296044 | Q_lesional_day15 | 717.14 | 74 |
GSM1296045 | Y_lesional_day15 | 265.23 | 56 |
GSM1296025 | C_lesional_day15 | 50.39 | 31 |
GSM1296033 | D_lesional_day15 | 209.51 | 53 |
GSM1296027 | I_lesional_day15 | 249.17 | 57 |
GSM1296032 | J_lesional_day15 | 57.6 | 33 |
GSM1296024 | K_lesional_day15 | 83.43 | 40 |
GSM1296031 | W_lesional_day15 | 44.7 | 29 |
GSM1296028 | X_lesional_day15 | 172.5 | 50 |
GSM1296029 | Z_lesional_day15 | 161.3 | 49 |
GSM1296026 | F_lesional_day15 | 40.11 | 27 |
GSM1296030 | O_lesional_day15 | 181.24 | 53 |
GSM1296040 | S_lesional_day15 | 36.62 | 26 |
GSM1296036 | T_lesional_day15 | 94.41 | 39 |
GSM1296048 | V_lesional_day15 | 197.28 | 52 |
GSM1296059 | A_lesional_day43 | 158.88 | 49 |
GSM1296066 | G_lesional_day43 | 516.63 | 68 |
GSM1296060 | R_lesional_day43 | 220.32 | 54 |
GSM1296063 | U_lesional_day43 | 72.31 | 36 |
GSM1296064 | E_lesional_day43 | 96.7 | 41 |
GSM1296067 | H_lesional_day43 | 298.49 | 58 |
GSM1296062 | M_lesional_day43 | 98.09 | 41 |
GSM1296068 | Q_lesional_day43 | 553.9 | 69 |
GSM1296050 | C_lesional_day43 | 11.47 | 10 |
GSM1296057 | D_lesional_day43 | 246.11 | 56 |
GSM1296052 | I_lesional_day43 | 284.27 | 59 |
GSM1296054 | J_lesional_day43 | 82.93 | 38 |
GSM1296049 | K_lesional_day43 | 75.5 | 37 |
GSM1296055 | W_lesional_day43 | 9.11 | 9 |
GSM1296053 | X_lesional_day43 | 278.55 | 57 |
GSM1296058 | Z_lesional_day43 | 104.04 | 43 |
GSM1296051 | F_lesional_day43 | 18.31 | 16 |
GSM1296056 | O_lesional_day43 | 159.93 | 50 |
GSM1296065 | S_lesional_day43 | 14.58 | 14 |
GSM1296061 | T_lesional_day43 | 80.13 | 37 |
GSM1296095 | A_non-lesional_pre-dose | 155.47 | 49 |
GSM1296120 | B_non-lesional_pre-dose | 295.18 | 58 |
GSM1296077 | C_non-lesional_pre-dose | 57.17 | 34 |
GSM1296093 | D_non-lesional_pre-dose | 297.37 | 58 |
GSM1296104 | E_non-lesional_pre-dose | 90.11 | 40 |
GSM1296079 | F_non-lesional_pre-dose | 42.92 | 29 |
GSM1296108 | G_non-lesional_pre-dose | 456.28 | 66 |
GSM1296110 | H_non-lesional_pre-dose | 407.28 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 294.44 | 59 |
GSM1296091 | J_non-lesional_pre-dose | 49.41 | 32 |
GSM1296075 | K_non-lesional_pre-dose | 16.02 | 15 |
GSM1296112 | L_non-lesional_pre-dose | ||
GSM1296100 | M_non-lesional_pre-dose | 167.06 | 49 |
GSM1296087 | O_non-lesional_pre-dose | 147.17 | 49 |
GSM1296118 | P_non-lesional_pre-dose | 185.97 | 49 |
GSM1296114 | Q_non-lesional_pre-dose | 776.13 | 75 |
GSM1296097 | R_non-lesional_pre-dose | 145.96 | 47 |
GSM1296106 | S_non-lesional_pre-dose | 35.46 | 25 |
GSM1296102 | U_non-lesional_pre-dose | 157.55 | 47 |
GSM1296122 | V_non-lesional_pre-dose | 148.63 | 46 |
GSM1296089 | W_non-lesional_pre-dose | 45.66 | 28 |
GSM1296083 | X_non-lesional_pre-dose | 173.95 | 50 |
GSM1296116 | Y_non-lesional_pre-dose | 398.59 | 63 |
GSM1296085 | Z_non-lesional_pre-dose | 154.36 | 48 |